Immune Response to COVID-19 Vaccine in Hematological Cancer Patients
Author Information
Author(s): Šušol Ondrej, Šušolová Barbora, Klempíř Ondřej, Navrátil Milan, Gumulec Jaromír, Kořístek Zdeněk, Ďuraš Juraj, Kaščák Michal, Mihályová Jana, Stejskal Lukáš, Jelínek Tomáš, Richterová Petra, Szeligová Lenka, Plonková Hana, Zuchnická Jana, Dluhošová Barbora, Demel Ivo, Buffa David, Hradská Katarína, Popková Tereza, Muroňová Ludmila, Lachnit Martin, Lančová Klára, Hájek Roman
Primary Institution: University Hospital Ostrava
Hypothesis
What is the antibody response to a third dose of mRNA COVID-19 vaccine in patients with hematological malignancies over a one-year period?
Conclusion
The study found that additional vaccine doses can improve antibody responses in patients with hematological malignancies, even among those who initially had poor responses.
Supporting Evidence
- Antibody response exceeded 74% throughout the 12-month follow-up.
- Lowest seroconversion was observed in patients treated with anti-CD20 therapy less than 6 months before vaccination.
- Patients with chronic myeloproliferative neoplasms and acute leukemia had comparable responses to healthy individuals.
Takeaway
This study shows that giving more vaccine doses can help people with blood cancers build better defenses against COVID-19.
Methodology
292 patients with hematological malignancies were vaccinated with a third dose of the mRNA vaccine and followed for 12 months to evaluate their antibody response.
Potential Biases
Potential bias in patient selection and response evaluation due to the nature of the study.
Limitations
The study may not represent all types of hematological malignancies and the follow-up was limited to one year.
Participant Demographics
Patients included those with acute leukemia, chronic lymphocytic leukemia, lymphoma, and multiple myeloma, with a mean age of 67 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website